Pamidronate De Sodium Hospira (Pamidronate Disodium)

Pamidronate Disodium, the active ingredient in Pamidronate De Sodium Hospira, is a bisphosphonate presented as a sterile powder for intravenous infusion use. It is employed in the management of calcium metabolism disorders, particularly in patients with malignant bone disease.

GNH USA supplies Pamidronate De Sodium Hospira as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Pamidronate Disodium is a bisphosphonate that acts on bone turnover pathways to manage several skeletal conditions. - Hypercalcemia of malignancy: reduces elevated calcium levels and alleviates related symptoms. - Bone metastases associated with solid tumours: helps prevent the development of skeletal‑related events. - Osteolytic multiple myeloma t     .... -  .... - .... ...